ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2.

Luo Q, Wu X, Zhang Y, Shu T, Ding F, Chen H, Zhao P, Chang W, Zhu X, Liu Z
Cancer Lett. 2018 Jul 28;427:9-17. doi: 10.1016/j.canlet.2018.04.013. Epub 2018 Apr 13. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.